-transparent.png){kind=logo}
In cancer and other therapeutic research, an interpretation of median survival times can and should take cure into account. With this qualification, an analysis of recently published data provides further statistically significant evidence in favor of cancer chronotherapy as compared to homeostatic therapy.
Related Publications
F Halberg, and
W Nelson, and
G Cornélissen, and
E Haus, and
L E Scheving, and
R A Good
January 1973,
Voprosy onkologii,
F Halberg, and
W Nelson, and
G Cornélissen, and
E Haus, and
L E Scheving, and
R A Good
October 1970,
Gan,
F Halberg, and
W Nelson, and
G Cornélissen, and
E Haus, and
L E Scheving, and
R A Good
September 1974,
Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles,
F Halberg, and
W Nelson, and
G Cornélissen, and
E Haus, and
L E Scheving, and
R A Good
October 1980,
Journal of medicinal chemistry,
F Halberg, and
W Nelson, and
G Cornélissen, and
E Haus, and
L E Scheving, and
R A Good
February 1975,
Endokrinologie,
F Halberg, and
W Nelson, and
G Cornélissen, and
E Haus, and
L E Scheving, and
R A Good
January 1975,
Bibliotheca haematologica,
F Halberg, and
W Nelson, and
G Cornélissen, and
E Haus, and
L E Scheving, and
R A Good
January 1970,
Archivum immunologiae et therapiae experimentalis,
F Halberg, and
W Nelson, and
G Cornélissen, and
E Haus, and
L E Scheving, and
R A Good
August 1972,
Gan,
F Halberg, and
W Nelson, and
G Cornélissen, and
E Haus, and
L E Scheving, and
R A Good
January 1977,
Farmakologiia i toksikologiia,
F Halberg, and
W Nelson, and
G Cornélissen, and
E Haus, and
L E Scheving, and
R A Good
January 1990,
Folia histochemica et cytobiologica,
